PitchBook-2025年三季度医疗技术公共报表和估值指南（英）-2025

报告摘要

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research

核心要点

1 week
30 days
90 days

报告信息

文件全名: 《PitchBook-2025年三季度医疗技术公共报表和估值指南（英）-2025-6页.pdf》
适合读者: 战略规划行业研究员
核心数据: broader markets in Q3 2025. The S&P 500 and Nasdaq gained 7.4% and 11.1%, respectively, as investors rallied around optimism
were Tempus AI (up 36.4%) and Johnson & Johnson (up 19.2%), while Baxter and Kenvue both declined over 20% in the quarter.
among the 13 largest medtech firms rising about 11%. Growth was led by Boston Scientific—a top acquirer over the past two
for revenue growth to moderate closer to the 6% to 7% range in 2025 and 2026. Meanwhile, after a tough post-pandemic period,
the life sciences sector is expected to rebound to roughly 6% growth next year, as large firms have rightsized operations and
核心议题: 医疗

常见问题

《PitchBook-2025年三季度医疗技术公共报表和估值指南（英）-2025》主要包含哪些内容?

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research核心数据:broader markets in Q3 2025. The S&P 500 and Nasdaq gained 7.4% and 11.1%, respectively, as investors rallied around optimism;were Tempus AI (up 36.4%) and Johnson & Johnson (up 19.2%), while Baxter and Kenvue both declined over 20% in the quarter.;among the 13 largest medtech firms rising about 11%. Growth was led by Boston Scientific—a top acquirer over the past two。

这份报告由哪家机构发布?

本报告由PitchBook发布,发布于 2025 年。

这份报告覆盖哪一年、篇幅多大?

覆盖 2025 年,全文约 6。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合战略规划、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了医疗等议题。